Latest RVNC reports update at 2024-05-09: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1

Revance Therapeutics RVNC

$ 4.29 0.47%

Revance Therapeutics Shares 2011-2024 | RVNC

Annual Shares Revance Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
84.6 M	72.7 M	67.5 M	58 M	43.5 M	36.2 M	30.1 M	28.1 M	24.3 M	19.4 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
84.6 M	19.4 M	46.4 M

Quarterly Shares Revance Therapeutics

2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
91.9 M	88 M	86.6 M	83.7 M	81.1 M	82.4 M	72.2 M	70.1 M	68.3 M	71.6 M	67.8 M	67.5 M	66.6 M	69.2 M	60.5 M	54.3 M	53.9 M	52.4 M	43.3 M	43.3 M	41.6 M	37 M	36.3 M	36.1 M	36 M	36.5 M	30.3 M	29.8 M	28.8 M	28.6 M	28.2 M	28.1 M	28 M	28.3 M	23.8 M	23.6 M	23.5 M	23.8 M	23.3 M	19.4 M	11.1 M	261 K	229 K	209 K	204 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
91.9 M	204 K	43.9 M